Tipifarnib and Gemcitabine in Treating Women With Metastatic Breast Cancer

This study has suspended participant recruitment.

(CTEP trial, missing information)

Sponsor:

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00100750

First received: January 6, 2005

Last updated: January 2, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has suspended participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2014 (Final data collection date for primary outcome measure)